Algeria’s hospital funding crisis hits Covid-19 response

Algeria’s public hospitals, already strained by years of underfunding, faced a critical test during the Covid-19 pandemic. According to السفير العربي, the crisis exposed deep structural weaknesses in hospital financing, with direct consequences for healthcare delivery and the broader economy. Entrepreneurs, business founders, and the Algerian diaspora are now assessing how these challenges could shape investment opportunities and policy shifts in the coming years.

The pandemic revealed a stark mismatch between funding and demand. Algeria’s Ministry of Health reported that public hospitals received only 40% of their requested budget for 2020, forcing facilities like Algiers’ Mustapha Pacha University Hospital and Oran’s EHU 1er Novembre to ration medical supplies. The shortfall, estimated at 120 billion Algerian dinars (approximately $900 million at the time), delayed the purchase of ventilators, oxygen concentrators, and personal protective equipment (PPE). Private clinics, which account for 15% of Algeria’s hospital beds, stepped in to fill some gaps but were limited by regulatory restrictions on importing medical equipment.

For entrepreneurs, the funding crisis has created both risks and openings. The government’s reliance on emergency imports—such as the 1,000 ventilators purchased from China in April 2020—highlighted Algeria’s dependence on foreign suppliers. Local manufacturers, including pharmaceutical companies like Saidal and Biopharm, saw a surge in demand for generic drugs and disinfectants, but struggled with raw material shortages. The Ministry of Industry later announced tax incentives for domestic producers of medical supplies, offering a 10-year exemption on corporate taxes for new factories. However, bureaucratic delays in approving licenses have slowed progress, with only three new PPE production lines operational by mid-2021.

The diaspora has played a role in bridging the gap. Remittances to Algeria reached $1.8 billion in 2020, according to the Bank of Algeria, with a portion directed toward healthcare initiatives. Algerian expatriates in France and Canada organized crowdfunding campaigns to purchase oxygen generators for hospitals in Tlemcen and Constantine. Some diaspora investors also explored partnerships with local startups developing telemedicine platforms, such as DZ Health, which saw a 300% increase in users during the pandemic. Yet, regulatory hurdles—including restrictions on foreign ownership in healthcare—have deterred larger investments.

The crisis has also strained Algeria’s social security system. The Caisse Nationale des Assurances Sociales des Travailleurs Salariés (CNAS) reported a 25% increase in reimbursement claims for Covid-19 treatments in 2020, adding pressure to its already fragile finances. The government responded by raising the health contribution rate for salaried workers from 1.5% to 2% in January 2021, a move that could reduce disposable income for employees and impact consumer spending. For businesses, this translates to higher payroll costs, particularly for small and medium-sized enterprises (SMEs) already grappling with the economic fallout of the pandemic.

Looking ahead, the hospital funding crisis could accelerate two trends. First, the government may push for greater public-private partnerships (PPPs) in healthcare, following the model of the new 400-bed hospital in Sétif, built in collaboration with Turkish firm Rönesans Holding. Second, Algeria’s pharmaceutical sector could see consolidation, with larger players like Saidal acquiring smaller firms to achieve economies of scale. The Ministry of Health has also signaled plans to digitize hospital management systems, creating opportunities for tech startups specializing in health data analytics.

For the diaspora, the crisis underscores the need for clearer investment pathways in Algeria’s healthcare sector. While remittances and crowdfunding provide short-term relief, long-term solutions will require policy reforms, such as easing restrictions on foreign direct investment (FDI) in medical infrastructure. The government’s recent decision to allow 100% foreign ownership in certain healthcare projects—announced in May 2021—could attract diaspora capital, but implementation remains uncertain.

Key takeaway for entrepreneurs
Algeria’s hospital funding crisis has exposed gaps in medical supply chains and healthcare infrastructure, creating opportunities for local manufacturers and tech startups. The government’s tax incentives for domestic production and potential PPPs offer entry points, but regulatory hurdles persist. Diaspora investors should monitor policy changes on foreign ownership, while businesses should prepare for higher social security costs and shifts in consumer spending.